Literature DB >> 31792853

Serum SCUBE-1 levels in patients with diabetic retinopathy.

Erel Icel1, Aykut Icel2, Cuma Mertoglu3, Nurdan Gamze Tasli4, Yucel Karakurt4, Turgay Ucak4, Murat Gunay3.   

Abstract

PURPOSE: Signal peptide-CUB-Epidermal growth factor-like domain-containing protein 1 (SCUBE-1) is a protein expressed on the cell surface of endothelial cells and platelets. We aimed to determine the alterations in SCUBE-1 levels in patients at different stages of diabetic retinopathy (DR).
MATERIALS AND METHODS: Participants were grouped into 4 regarding the presence and stage of diabetic retinopathy as follows: control group (n 32), patients without DR (n 39), patients with background DR (n 42) and patients with proliferative DR (n 55). Age, gender, duration of diabetes, fasting blood glucose levels, serum hemoglobin A1c (HbA1c), SCUBE-1 and malondialdehyde (MDA) levels of the patients were recorded. Central macular thickness and central macular volume were recorded and compared between groups.
RESULTS: Totally 136 patients with diabetes mellitus and 32 control cases were included in the study. There is a significant increase in SCUBE-1 and MDA levels with an advance in DR. In correlation analysis, there was only a significant correlation present between serum SCUBE-1 and MDA levels (p 0.001) but not with other parameters.
CONCLUSION: For the first time in literature, we determined a significant increase in SCUBE-1 levels in patients with DR. Moreover, with an advance in DR, SCUBE-1 levels were also increasing.

Entities:  

Keywords:  Diabetic retinopathy; Malondialdehyde; SCUBE-1

Mesh:

Substances:

Year:  2019        PMID: 31792853     DOI: 10.1007/s10792-019-01249-8

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  25 in total

Review 1.  Early onset type 2 diabetes: risk factors, clinical impact and management.

Authors:  Emma Wilmot; Iskandar Idris
Journal:  Ther Adv Chronic Dis       Date:  2014-11       Impact factor: 5.091

2.  Identification of a novel family of cell-surface proteins expressed in human vascular endothelium.

Authors:  Ruey-Bing Yang; Chi Kin Domingos Ng; Scott M Wasserman; Steven D Colman; Suresh Shenoy; Fuad Mehraban; Laszlo G Komuves; James E Tomlinson; James N Topper
Journal:  J Biol Chem       Date:  2002-09-21       Impact factor: 5.157

3.  SCUBE 1: A novel biomarker related to platelet activation and atherothrombosis.

Authors:  Luís Bronze
Journal:  Rev Port Cardiol (Engl Ed)       Date:  2018-05

4.  Retinal Neurodegeneration in Diabetic Patients Without Diabetic Retinopathy.

Authors:  Joana Tavares Ferreira; Marta Alves; Arnaldo Dias-Santos; Lívio Costa; Bruno Oliveira Santos; João Paulo Cunha; Ana Luísa Papoila; Luís Abegão Pinto
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-11-01       Impact factor: 4.799

5.  Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion.

Authors:  Yukihiko Suzuki; Mitsuru Nakazawa; Kaori Suzuki; Hitoshi Yamazaki; Yasuhiro Miyagawa
Journal:  Jpn J Ophthalmol       Date:  2011-05-03       Impact factor: 2.447

6.  Expression of apoptosis markers in the retinas of human subjects with diabetes.

Authors:  Ahmed M Abu-El-Asrar; Lieve Dralands; Luc Missotten; Ibrahim A Al-Jadaan; Karel Geboes
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-08       Impact factor: 4.799

7.  Relationship of macular microcirculation and retinal thickness with visual acuity in diabetic macular edema.

Authors:  Kumi Sakata; Hideharu Funatsu; Seiyo Harino; Hidetaka Noma; Sadao Hori
Journal:  Ophthalmology       Date:  2007-04-18       Impact factor: 12.079

Review 8.  Global prevalence and major risk factors of diabetic retinopathy.

Authors:  Joanne W Y Yau; Sophie L Rogers; Ryo Kawasaki; Ecosse L Lamoureux; Jonathan W Kowalski; Toke Bek; Shih-Jen Chen; Jacqueline M Dekker; Astrid Fletcher; Jakob Grauslund; Steven Haffner; Richard F Hamman; M Kamran Ikram; Takamasa Kayama; Barbara E K Klein; Ronald Klein; Sannapaneni Krishnaiah; Korapat Mayurasakorn; Joseph P O'Hare; Trevor J Orchard; Massimo Porta; Mohan Rema; Monique S Roy; Tarun Sharma; Jonathan Shaw; Hugh Taylor; James M Tielsch; Rohit Varma; Jie Jin Wang; Ningli Wang; Sheila West; Liang Xu; Miho Yasuda; Xinzhi Zhang; Paul Mitchell; Tien Y Wong
Journal:  Diabetes Care       Date:  2012-02-01       Impact factor: 19.112

9.  High Glucose Induces Mitochondrial Dysfunction in Retinal Müller Cells: Implications for Diabetic Retinopathy.

Authors:  Thomas Tien; Joyce Zhang; Tetsuya Muto; Dongjoon Kim; Vijay P Sarthy; Sayon Roy
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-06-01       Impact factor: 4.799

10.  The effects of macular ischemia on visual acuity in diabetic retinopathy.

Authors:  Dawn A Sim; Pearse A Keane; Javier Zarranz-Ventura; Simon Fung; Michael B Powner; Elise Platteau; Catey V Bunce; Marcus Fruttiger; Praveen J Patel; Adnan Tufail; Catherine A Egan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-28       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.